Reuters logo
BRIEF-Kubota Pharmaceutical Holdings says unit Acucela receives patent covering method of use for emixustat hydrochloride
September 11, 2017 / 1:44 AM / 10 days ago

BRIEF-Kubota Pharmaceutical Holdings says unit Acucela receives patent covering method of use for emixustat hydrochloride

Sept 11 (Reuters) - Kubota Pharmaceutical Holdings Co Ltd

* Says unit Acucela Inc received a patent (No. 9,737,496 B2) covering method of use for emixustat hydrochloride from the United States Patent and Trademark Office (USPTO)

Source text in Japanese:goo.gl/GDpJ2E

Further company coverage: (Beijing Headline News)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below